Global Prostate Cancer Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4867697
- 100 Pages
- February 2022
- Medical Devices
The United States Prostate Cancer Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prostate Cancer Therapeutics market, reaching US$ million by the year 2028. As for the Europe Prostate Cancer Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Prostate Cancer Therapeutics players cover Sanofi, Pfizer, Amgen, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Drugs
Medical Devices
Segmentation by sale channel: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Retail Pharmacy
Online Sales
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Pfizer
Amgen
Johnson & Johnson
AstraZeneca
AbbVie
Bayer
Ipsen Group
Endo Pharmaceuticals
Dendreon Corporation(Sanpower Group Co. Ltd.)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Therapeutics Market Size 2017-2028
2.1.2 Prostate Cancer Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Prostate Cancer Therapeutics Segment by Type
2.2.1 Drugs
2.2.2 Medical Devices
2.3 Prostate Cancer Therapeutics Market Size by Type
2.3.1 Prostate Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Prostate Cancer Therapeutics Segment by Sale Channel
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Sales
2.5 Prostate Cancer Therapeutics Market Size by Sale Channel
2.5.1 Prostate Cancer Therapeutics Market Size CAGR by Sale Channel (2017 VS 2022 VS 2028)
2.5.2 Global Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2022)
3 Prostate Cancer Therapeutics Market Size by Player
3.1 Prostate Cancer Therapeutics Market Size Market Share by Players
3.1.1 Global Prostate Cancer Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Prostate Cancer Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Prostate Cancer Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Cancer Therapeutics by Regions
4.1 Prostate Cancer Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Prostate Cancer Therapeutics Market Size Growth (2017-2022)
4.3 APAC Prostate Cancer Therapeutics Market Size Growth (2017-2022)
4.4 Europe Prostate Cancer Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Prostate Cancer Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Prostate Cancer Therapeutics Market Size by Country (2017-2022)
5.2 Americas Prostate Cancer Therapeutics Market Size by Type (2017-2022)
5.3 Americas Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Therapeutics Market Size by Region (2017-2022)
6.2 APAC Prostate Cancer Therapeutics Market Size by Type (2017-2022)
6.3 APAC Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostate Cancer Therapeutics by Country (2017-2022)
7.2 Europe Prostate Cancer Therapeutics Market Size by Type (2017-2022)
7.3 Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prostate Cancer Therapeutics Market Forecast
10.1 Global Prostate Cancer Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Prostate Cancer Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Prostate Cancer Therapeutics Forecast
10.1.3 APAC Prostate Cancer Therapeutics Forecast
10.1.4 Europe Prostate Cancer Therapeutics Forecast
10.1.5 Middle East & Africa Prostate Cancer Therapeutics Forecast
10.2 Americas Prostate Cancer Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Prostate Cancer Therapeutics Market Forecast
10.2.2 Canada Prostate Cancer Therapeutics Market Forecast
10.2.3 Mexico Prostate Cancer Therapeutics Market Forecast
10.2.4 Brazil Prostate Cancer Therapeutics Market Forecast
10.3 APAC Prostate Cancer Therapeutics Forecast by Region (2023-2028)
10.3.1 China Prostate Cancer Therapeutics Market Forecast
10.3.2 Japan Prostate Cancer Therapeutics Market Forecast
10.3.3 Korea Prostate Cancer Therapeutics Market Forecast
10.3.4 Southeast Asia Prostate Cancer Therapeutics Market Forecast
10.3.5 India Prostate Cancer Therapeutics Market Forecast
10.3.6 Australia Prostate Cancer Therapeutics Market Forecast
10.4 Europe Prostate Cancer Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Prostate Cancer Therapeutics Market Forecast
10.4.2 France Prostate Cancer Therapeutics Market Forecast
10.4.3 UK Prostate Cancer Therapeutics Market Forecast
10.4.4 Italy Prostate Cancer Therapeutics Market Forecast
10.4.5 Russia Prostate Cancer Therapeutics Market Forecast
10.5 Middle East & Africa Prostate Cancer Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Prostate Cancer Therapeutics Market Forecast
10.5.2 South Africa Prostate Cancer Therapeutics Market Forecast
10.5.3 Israel Prostate Cancer Therapeutics Market Forecast
10.5.4 Turkey Prostate Cancer Therapeutics Market Forecast
10.5.5 GCC Countries Prostate Cancer Therapeutics Market Forecast
10.6 Global Prostate Cancer Therapeutics Forecast by Type (2023-2028)
10.7 Global Prostate Cancer Therapeutics Forecast by Sale Channel (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Prostate Cancer Therapeutics Product Offered
11.1.3 Sanofi Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Prostate Cancer Therapeutics Product Offered
11.2.3 Pfizer Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Prostate Cancer Therapeutics Product Offered
11.3.3 Amgen Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Amgen Main Business Overview
11.3.5 Amgen Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Prostate Cancer Therapeutics Product Offered
11.4.3 Johnson & Johnson Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Prostate Cancer Therapeutics Product Offered
11.5.3 AstraZeneca Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Prostate Cancer Therapeutics Product Offered
11.6.3 AbbVie Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Prostate Cancer Therapeutics Product Offered
11.7.3 Bayer Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Ipsen Group
11.8.1 Ipsen Group Company Information
11.8.2 Ipsen Group Prostate Cancer Therapeutics Product Offered
11.8.3 Ipsen Group Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Ipsen Group Main Business Overview
11.8.5 Ipsen Group Latest Developments
11.9 Endo Pharmaceuticals
11.9.1 Endo Pharmaceuticals Company Information
11.9.2 Endo Pharmaceuticals Prostate Cancer Therapeutics Product Offered
11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Endo Pharmaceuticals Main Business Overview
11.9.5 Endo Pharmaceuticals Latest Developments
11.10 Dendreon Corporation(Sanpower Group Co. Ltd.)
11.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Company Information
11.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product Offered
11.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Main Business Overview
11.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Latest Developments
12 Research Findings and Conclusion
Table 1. Prostate Cancer Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Drugs
Table 3. Major Players of Medical Devices
Table 4. Prostate Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Prostate Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Prostate Cancer Therapeutics Market Size CAGR by Sale Channel (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 9. Global Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 10. Global Prostate Cancer Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Prostate Cancer Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Prostate Cancer Therapeutics Key Players Head office and Products Offered
Table 13. Prostate Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Prostate Cancer Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Prostate Cancer Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Prostate Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Prostate Cancer Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Prostate Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 23. Americas Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 24. APAC Prostate Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Prostate Cancer Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Prostate Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 29. APAC Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 30. Europe Prostate Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Prostate Cancer Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Prostate Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 35. Europe Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 36. Middle East & Africa Prostate Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Prostate Cancer Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Prostate Cancer Therapeutics
Table 43. Key Market Challenges & Risks of Prostate Cancer Therapeutics
Table 44. Key Industry Trends of Prostate Cancer Therapeutics
Table 45. Global Prostate Cancer Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Prostate Cancer Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Prostate Cancer Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Prostate Cancer Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Prostate Cancer Therapeutics Market Size Forecast by Sale Channel (2023-2028) & ($ Millions)
Table 50. Global Prostate Cancer Therapeutics Market Size Market Share Forecast by Sale Channel (2023-2028)
Table 51. Sanofi Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 52. Sanofi Prostate Cancer Therapeutics Product Offered
Table 53. Sanofi Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. Pfizer Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 57. Pfizer Prostate Cancer Therapeutics Product Offered
Table 58. Pfizer Main Business
Table 59. Pfizer Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Pfizer Latest Developments
Table 61. Amgen Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 62. Amgen Prostate Cancer Therapeutics Product Offered
Table 63. Amgen Main Business
Table 64. Amgen Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Amgen Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 67. Johnson & Johnson Prostate Cancer Therapeutics Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Johnson & Johnson Latest Developments
Table 71. AstraZeneca Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 72. AstraZeneca Prostate Cancer Therapeutics Product Offered
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. AstraZeneca Latest Developments
Table 76. AbbVie Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 77. AbbVie Prostate Cancer Therapeutics Product Offered
Table 78. AbbVie Main Business
Table 79. AbbVie Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. AbbVie Latest Developments
Table 81. Bayer Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 82. Bayer Prostate Cancer Therapeutics Product Offered
Table 83. Bayer Main Business
Table 84. Bayer Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Bayer Latest Developments
Table 86. Ipsen Group Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 87. Ipsen Group Prostate Cancer Therapeutics Product Offered
Table 88. Ipsen Group Main Business
Table 89. Ipsen Group Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Ipsen Group Latest Developments
Table 91. Endo Pharmaceuticals Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 92. Endo Pharmaceuticals Prostate Cancer Therapeutics Product Offered
Table 93. Endo Pharmaceuticals Main Business
Table 94. Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Endo Pharmaceuticals Latest Developments
Table 96. Dendreon Corporation(Sanpower Group Co. Ltd.) Details, Company Type, Prostate Cancer Therapeutics Area Served and Its Competitors
Table 97. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product Offered
Table 98. Dendreon Corporation(Sanpower Group Co. Ltd.) Main Business
Table 99. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Dendreon Corporation(Sanpower Group Co. Ltd.) Latest Developments
List of Figures
Figure 1. Prostate Cancer Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Prostate Cancer Therapeutics Market Size Market Share by Type in 2021
Figure 7. Prostate Cancer Therapeutics in Hospital Pharmacy
Figure 8. Global Prostate Cancer Therapeutics Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Prostate Cancer Therapeutics in Retail Pharmacy
Figure 10. Global Prostate Cancer Therapeutics Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Prostate Cancer Therapeutics in Online Sales
Figure 12. Global Prostate Cancer Therapeutics Market: Online Sales (2017-2022) & ($ Millions)
Figure 13. Global Prostate Cancer Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 14. Global Prostate Cancer Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Prostate Cancer Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Prostate Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Prostate Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Prostate Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Prostate Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Prostate Cancer Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Prostate Cancer Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Prostate Cancer Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 23. United States Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Prostate Cancer Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Prostate Cancer Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 29. China Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Prostate Cancer Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Prostate Cancer Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Prostate Cancer Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 38. Germany Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Prostate Cancer Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Prostate Cancer Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Prostate Cancer Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 46. Egypt Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Prostate Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Prostate Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
